Le Lézard
Classified in: Health, Science and technology

Student Mental Health Program "Move This World" Announces Additional Offerings for 2024-2025 Academic Year


Social emotional skills platform offers additional proactive and preventive services: Tier 2 support, increased voice and choice for secondary students, family-school connections, professional wellness, and Spanish language expansion in the 2024-2025 school year.

BROOKLYN, N.Y., April 29, 2024 /PRNewswire-PRWeb/ -- Move This World, an evidence-based PreK-12 curriculum for social emotional skills used by over four million students in the U.S., announces today expanded capabilities for the 2024-2025 academic year. The offerings will help time-constrained teachers using Move This World to foster reflection, processing, and connection among students and address the growing need for mental health support in education settings.

"When students can identify, express, and manage emotions constructively, students, schools, and families see more success." - Sara Potler LaHayne, Founder and CEO of Move This World

Amidst escalating demands for mental wellness initiatives, school districts must find proactive programs to assist students in navigating their complex emotions. Using easy-to-implement multimedia modules, Move This World has been proven to decrease behavioral incidents and increase success academically and in life beyond the classroom.

In the 2024-2025 school year, districts using Move This World will now have access to multi-tiered systems of support, including Tier 2 courses tailored to students requiring specific and targeted skill development. Additionally, middle school and high school students will benefit from personalized digital spaces, empowering them to manage stress, process emotions, and track their social emotional development.

Sara Potler LaHayne, Founder and CEO of Move This World, emphasized the impact of the program's ability to teach essential skills to effectively navigate daily stressors. "We keep it simple. By providing authentic and engaging content that teachers can easily add into an existing curriculum, Move This World helps students go from frazzled to functional. When they can identify, express, and manage emotions constructively, students, schools, and families see more success," she stated.

Key highlights of Move This World's enhanced offerings for the 2024-25 academic year include:

These improvements are all in addition to the existing Tier 1 program that is used across the country. LaHayne added, "We were thrilled to validate our positive impact this year with third-party research that showed higher emotional competencies and improved academics at schools participating in Move This World's existing curriculum. These updates will extend that reach even further."

Media Contact

Clare Carr, Move This World, 1 4402780064, [email protected], https://www.movethisworld.com/

SOURCE Move This World


These press releases may also interest you

at 16:35
Geron Corporation , a late-stage clinical biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 2,910,780 shares of Geron common stock as inducements to newly hired employees in...

at 16:15
Quest Diagnostics , a leading provider of diagnostic information services, today announced that its Board of Directors has elected Robert (Rob) B. Carter, a seasoned technology executive, to serve as a director. Including Mr. Carter, the company's...

at 16:14
Just as Life Time continues to add to its portfolio of athletic country clubs across the nation ? now totaling more than 170 across 31 states and 43 major markets including Toronto ? the company is taking its commitment to inspire healthy, happy...

at 16:11
A new partnership between the Registered Nurses' Association of Ontario (RNAO) and the Indigenous Primary Health Care Council (IPHCC) aims to build a reciprocal relationship that fosters Indigenous representation at decision-making tables within RNAO...

at 16:10
Contineum Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments for the treatment of...

at 16:10
Savara Inc. , a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to a new employee. On May 14, 2024, the Compensation Committee of Savara's Board of Directors granted the...



News published on and distributed by: